- Home
- OBIO vs INAC Comparison
OBIO vs INAC Comparison
Compare OBIO & INAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- INAC
- Stock Information
- Founded
- OBIO 2017
- INAC 2024
- Country
- OBIO United States
- INAC United States
- Employees
- OBIO N/A
- INAC N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- INAC
- Sector
- OBIO Health Care
- INAC
- Exchange
- OBIO Nasdaq
- INAC Nasdaq
- Market Cap
- OBIO 147.8M
- INAC 143.2M
- IPO Year
- OBIO N/A
- INAC 2025
- Fundamental
- Price
- OBIO $2.75
- INAC $9.95
- Analyst Decision
- OBIO Strong Buy
- INAC
- Analyst Count
- OBIO 4
- INAC 0
- Target Price
- OBIO $14.00
- INAC N/A
- AVG Volume (30 Days)
- OBIO 339.4K
- INAC 17.9K
- Earning Date
- OBIO 08-12-2025
- INAC 01-01-0001
- Dividend Yield
- OBIO N/A
- INAC N/A
- EPS Growth
- OBIO N/A
- INAC N/A
- EPS
- OBIO N/A
- INAC N/A
- Revenue
- OBIO $2,944,000.00
- INAC N/A
- Revenue This Year
- OBIO $19.83
- INAC N/A
- Revenue Next Year
- OBIO $12.53
- INAC N/A
- P/E Ratio
- OBIO N/A
- INAC N/A
- Revenue Growth
- OBIO 41.61
- INAC N/A
- 52 Week Low
- OBIO $2.37
- INAC $10.01
- 52 Week High
- OBIO $6.50
- INAC $10.40
- Technical
- Relative Strength Index (RSI)
- OBIO 50.09
- INAC N/A
- Support Level
- OBIO $2.65
- INAC N/A
- Resistance Level
- OBIO $3.08
- INAC N/A
- Average True Range (ATR)
- OBIO 0.16
- INAC 0.00
- MACD
- OBIO 0.03
- INAC 0.00
- Stochastic Oscillator
- OBIO 52.86
- INAC 0.00
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About INAC Indigo Acquisition Corp. Ordinary Shares
Indigo Acquisition Corp is a blank check company.